ReviewInteraction of pregnancy and autoimmune rheumatic disease
Introduction
Pregnancy induces dramatic immune and neuroendocrine alterations in the maternal body in order to protect the fetus from immunologic attack by the mother [1]. Instead of a general immunosuppression that would weaken the mother's defence against infection, rather a modulation of composition and function of immune-competent cells and immune-modulatory molecules takes place in the maternal system during pregnancy [2]. There is a cross-talk between mother and fetus from early on which helps to accommodate the fetus in the uterus, and supports nidation, placentation and fetal growth and development. On the other hand, the fetus promotes tolerance to paternal antigens by migration of fetal cells and cell-free fetal DNA into the maternal circulation during normal pregnancy. Fetal cells remain in the mother for decades, and create a state of microchimerism in the mother [3].
After delivery, the maternal body adjusts again to a non-pregnant state, which is not simply a return to the condition before conception, but takes place still under the influence of the immune activation at parturition [4]. Furthermore, lactation affects immune functions which may modulate activity of autoimmune diseases. The profound immunologic adaptions necessary for maternal tolerance toward the fetus in pregnancy and the immunologic reset to a non-pregnant state thereafter, do influence maternal autoimmune rheumatic diseases in several ways. One is triggering the onset of a rheumatic disease in the post partum period, the other influencing disease activity of established rheumatic disease.
Section snippets
Onset of arthritis
An increased incidence of autoimmune diseases has been observed in the post partum period [5]. In a Norwegian, population based study 37.7% out of 183 patients with rheumatoid arthritis (RA) and 28.2% out of 110 patients with other chronic arthritides (OCA) including psoriatic arthritis, ankylosing spondylitis (AS) and undifferentiated arthritis were diagnosed during the first 24 months after delivery (p = 0.09). The incidence rate ratio for diagnosis during 0–24 months versus 25–48 months post
The influence of pregnancy on established rheumatic disease
A marked beneficial effect of pregnancy is observed in rheumatoid arthritis (RA) whereas several other rheumatic diseases as ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE) show either no particular effect or an aggravation of symptoms during pregnancy. This observation is an indication of different pathophysiology at work in rheumatic diseases which results in a different response to the complex changes of pregnancy. In this survey, modulation of disease activity, not
The immune response in pregnancy
The unique condition of pregnancy with a peaceful coexistence of genetically different individuals has initiated a lot of research aimed at understanding the mechanism of tolerance. In parallel, also the beneficial or adverse effects of pregnancy on autoimmune diseases have been investigated. In the following a brief overview of several aspects of this research is presented in the context of rheumatic disease.
Pregnancy induces substantial changes in hormone levels starting with hormones
The immune response during pregnancy in healthy and diseased rheumatic women: presentation of own studies
The different clinical response of RA, AS and SLE to pregnancy initiated research into gestational factors influencing disease symptoms which is presented in the following.
Different aspects of the modulation of disease activity during and after pregnancy was studied by us in pregnant women with RA and AS and compared to findings in healthy pregnant women. The clinical differences observed in own prospective studies between pregnant patients with RA and AS [102] initiated studies of the cytokine
Aspects of different responses of rheumatic disease to pregnancy
As discussed above, investigations into the immunology of pregnancy can, at least in part, explain the amelioration of RA during pregnancy. By contrast, the sustained activity of SLE and AS, and even the propensity to flare during pregnancy has been much less investigated (Fig. 3).
Conclusion
The different responses of rheumatic diseases to pregnancy shed light on pathogenetic mechanisms important for disease onset and the activity of established disease. The gender disparity with higher incidence of autoimmune disease among women than among men might to some extent depend on reproduction. Research into factors promoting disease onset has revealed the possibility that disease susceptibility genes can be acquired through fetal cells in a woman without disease specific HLA alleles or
Disclosure
The authors declare no competing interests.
- 1.
Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, et al. (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374: 451–458.
- 2.
Robb RJ, Kreijveld E, Kuns RD, Wilson YA, Olver SD, et al. Type I-IFNs control GVHD and GVL responses after transplantation. Blood 118: 3399–3409.
References (133)
- et al.
Changes in immune activation markers during pregnancy and postpartum
J Reprod Immunol
(1999) - et al.
Pregnancy and rheumatoid arthritis
Rheum Dis Clin North Am
(1997) - et al.
The genetic basis of rheumatoid arthritis. The shared epitope hypothesis
Rheum Dis Clin North Am
(1992) - et al.
Spondyloarthritides in females
Bailliére's Clin Rheumatol
(1998) - et al.
Lupus pregnancy. Case–control prospective study demonstrating absence of lupus exacerbation during or after pregnancy
Am J Med
(1984) - et al.
Systemic lupus erythematosus flares during pregnancy
Rheum Dis Clin North Am
(1997) - et al.
Interleukin messenger ribonucleic acid in human placenta: Implications of a role for interleukin-10 in fetal allograft protection
Am J Obstet Gynecol
(1995) - et al.
Cytokines in recurrent pregnancy loss
Clin Chim Acta
(2011) - et al.
Tumor necrosis factor, interleukin 1, and interleukin-6 in normal human pregnancy
Am J Obstet Gynecol
(1993) - et al.
Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia
Obstet Gynecol
(1996)
Increased levels of cytokines and cytokine activity modifiers in normal pregnancy
Eur J Obstet Gynecol Reprod Biol
Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid
Am J Obstet Gynecol
Longitudinal modulation of immune system cytokine profile during pregnancy
Cytokine
Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus
Hum Immunol
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Blood
Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice
J Neuroimmunol
Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells
J Reprod Immunol
Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates
Symp Soc Exp Biol
Gimme shelter: the immune system during pregnancy
Immunol Rev
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
Proc Natl Acad Sci U S A
Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy
Immunol Invest
Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry
Ann Rheum Dis
The Scientific Advisory Committee of the Empire Rheumatism Council. A controlled investigation into the aetiology and clinical features of rheumatoid arthritis
BMJ
Effect of pregnancy on the onset and course of rheumatoid arthritis
Ann Rheum Dis
Prediction of postpartum onset of rheumatoid arthritis
Ann Rheum Dis
Timing of pregnancy in relation to the onset of rheumatoid arthritis
Arthritis Rheum
The onset of rheumatoid arthritis in relation to pregnancy and childbirth
Clin Exp Rheumatol
Pregnancy and the risk of developing rheumatoid arthritis
Arthritis Rheum
The pill, parity, and rheumatoid arthritis
Arthritis Rheum
Nulliparity as a risk factor for rheumatoid arthritis
Arthritis Rheum
Breast-feeding and the onset of rheumatoid arthritis
Arthritis Rheum
Transfer of shared epitope through microchimerism in women with rheumatoid arthritis
Arthritis Rheum
Acquisition of the rheumatoid arthritis shared epitope through microchimerism
Arthritis Rheum
Does pregnancy provide vaccine-like protection against rheumatoid arthritis?
Arthritis Rheum
Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis
N Engl J Med
HLA sharing and history of miscarriage among women with rheumatoid arthritis
Am J Hum Genet
Arthritis in mice: allogeneic pregnancy protects more than syngeneic by attenuating cellular immune response
J Rheumatol
Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann
Am J Reprod Immunol
Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother
Ann Rheum Dis
Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy
J Rheumatol
Prospective study of fetal DNA in serum and Disease Activity During Pregnancy in Women with inflammatory Arthritis
Arthritis Rheum
A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis
Arthritis Rheum
Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy
Arthritis Rheum
Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study
Arthritis Rheum
Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy
Ann Rheum Dis
Ankylosing spondylitis and motherhood
Arthritis Rheum
Ankylosing spondylitis - the female aspect
J Rheumatol
Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach
J Rheumatol
Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience
Arthritis Rheum
Outcome of pregancy in patients with systemic lupus erythematosus. A prospective study
Arch Intern Med
Cited by (94)
Systemic lupus erythematosus and pregnancy: Strategies before, during and after pregnancy to improve outcomes
2021, Revista Colombiana de ReumatologiaOut of balance: the role of evolutionary mismatches in the sex disparity in autoimmune disease
2021, Medical HypothesesThe prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities
2020, Journal of Thrombosis and HaemostasisReproductive Failure
2019, Mosaic of Autoimmunity: The Novel Factors of Autoimmune DiseasesPostpartum hemoptysis as presenting sign of longstanding vasculitis
2018, International Journal of Obstetric AnesthesiaTargeted drugs in spondyloarthritis during pregnancy and lactation
2018, Pharmacological Research